Archives

by in
Entry Author Date Location
Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs 05/22/13 Boston
Fighting a Global War on Rare Diseases 03/20/13 New York
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
NPS Wins First FDA Approval, for Short Bowel Syndrome Drug 12/21/12 New York
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More 10/19/12 New York
Biotech Racking Up Successes Against Ultra-Orphan Diseases 10/15/12 New York
NPS Rejiggers Amgen Deal, Sees $75M Extra Cash 07/02/12 New York
NPS Rallies as Good News Flows for Two Rare-Disease Drugs 06/25/12 New York
Lessons on Bouncing Back From Disaster 12/08/11 New York
NPS Charts Positive Results on Parathyroid Drug 11/07/11 New York
NPS Pharma’s Not-So-Excellent Wall Street Adventure 11/03/11 New York
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
NPS Re-Jiggers Glaxo Partnership, Finds Value in Ultra-Orphan Diseases 08/09/11 New York
NPS Earns Seven-Figure Milestone Payment 03/28/11 New York
Page 1 of 1